Please login to the form below

Not currently logged in
Email:
Password:

New EU rules on falsified medicines

The European Union has published a new directive to prevent falsified or counterfeit medicines entering the legal supply chain

The European Union has published a new Directive (pdf) to prevent falsified or counterfeit medicines entering the legal supply chain.

Published in the Official Journal of the European Union, the directive outlines regulation to increase safety and strengthen control measures across the continent.

Methods include obligatory features on the outer packaging of medicines to demonstrate authenticity; strengthened requirements for the inspection of the manufacturers of pharmaceutical ingredients; and enforcing an obligation for manufacturers and distributors to report any suspicion of falsified medicines.

A logo that must also be placed on the websites of legally operating online pharmacies, with a link to official national registers.

The European Medicines Agency (EMA) said it welcomed the rules, and that the agency would be working closely with the European Commission over the next 18 months to implement the legislation.

The Directive is scheduled to come into force on July 21, 2011, with the application of its measures necessary from all Member States by January, 2013.

5th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...
image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...

Infographics